Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine

Abstract Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare lymphoma with an aggressive clinical course and a dismal outcome. The prognosis is linked to a pronounced resistance to chemotherapy and radiotherapy. No standard treatment approach is defined due to the low frequency o...

Full description

Bibliographic Details
Main Authors: Sophie Voruz, Laurence de Leval, Anne Cairoli
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Experimental Hematology & Oncology
Subjects:
Primary cutaneous gamma-delta T-cell lymphoma
Targeted treatment
Cutaneous T-cell lymphoma
Refractory disease
Online Access:https://doi.org/10.1186/s40164-021-00225-2

Internet

https://doi.org/10.1186/s40164-021-00225-2

Similar Items